Drugs Containing Excipient (Inactive Ingredient) METHYL GLUCETH-20

Branded drugs containing METHYL GLUCETH-20 excipient, and estimated key patent expiration / generic entry dates

Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Bausch Health US LLC	CARAC	fluorouracil	0187-5200	METHYL GLUCETH-20
Mylan Pharmaceuticals Inc	FLUOROURACIL CREAM	fluorouracil	0378-8078	METHYL GLUCETH-20
Dr Reddy's Laboratories Inc	FLUOROURACIL	fluorouracil cream, 0.5%	75907-169	METHYL GLUCETH-20

Generic drugs containing METHYL GLUCETH-20 excipient

Company	Ingredient	NDC	Excipient
Bausch Health US LLC	fluorouracil	0187-5200	METHYL GLUCETH-20
Mylan Pharmaceuticals Inc	fluorouracil	0378-8078	METHYL GLUCETH-20
Dr Reddy's Laboratories Inc	fluorouracil cream, 0.5%	75907-169	METHYL GLUCETH-20

Market Dynamics and Financial Trajectory for Methyl Gluceth-20

Last updated: March 26, 2026

What is Methyl Gluceth-20?

Methyl Gluceth-20 is a water-soluble, synthetic humectant and skin-conditioning agent primarily used in cosmetic and dermatological formulations. It is derived from glucose and glycerin, featuring moisturizing properties that enhance product appeal. The compound has applications in various skincare products, including creams, lotions, and serums, with a focus on hydration and skin barrier repair.

Market Overview

The global pharmaceutical excipient market valued approximately USD 6 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 6-8% through 2028. Within this, the segment for cosmetic and dermatological excipients, including Methyl Gluceth-20, is expanding due to increased demand for skin-care products with moisturizing benefits.

Key Drivers

• Rising consumer awareness of skin health and aging control.
• Growing preference for natural and skin-friendly ingredients.
• Increased R&D investment by pharma and cosmetic companies.
• Regulatory acceptance of safe excipients in topical formulations.

Regional Markets

Region	Market Share (2022)	Expected CAGR (2023-2028)	Key Factors
North America	35%	6.5%	High cosmetic R&D activity, stringent regulations
Europe	25%	7.0%	Mature skincare market, demand for advanced formulations
Asia-Pacific	30%	8.5%	Rapid urbanization, rising disposable incomes, growth in personalized skincare
Rest of World	10%	6.0%	Emerging markets with increasing cosmetic consumption

Competitive Landscape

Major players producing Methyl Gluceth-20 include:

• Evonik Industries AG
• DOW Chemical Company
• Ashland Global Holdings Inc.
• BASF SE
• Symrise AG

These companies differentiate on manufacturing capacity, regulatory compliance, and product purity. Contract manufacturers, or CMOs, are also active, with some offering custom synthesis.

Patent and Regulatory Status

While specific patents on Methyl Gluceth-20 are limited, regulations governing excipients, including the EU’s Annexes and FDA’s INCI list, approve its use in topical products. The US FDA classifies it as generally recognized as safe (GRAS) for cosmetic applications.

Financial Trajectory and Investment Outlook

Revenue and Pricing Trends

• The segment for moisturizing excipients like Methyl Gluceth-20 is seeing price stability due to raw material costs and high demand.
• Entry barriers are low; new entrants can potentially disrupt supply through alternative humectants like glycerin derivatives or plant-based options.
• Premium formulations using high-purity or unique derivatives fetch higher margins.

R&D and Innovation Impact

• R&D investments targeting skin hydration and barrier repair are expected to fuel new product development.
• Adoption of clean-label formulations increases demand for plant-based or natural substitutes, potentially affecting Methyl Gluceth-20’s market share.

Supply Chain Factors

• Raw material availability (glucose, glycerol) influences pricing.
• Logistics disruptions caused by global crises impact manufacturing costs.
• Regulatory compliance costs may increase, affecting profit margins.

Forecasted Growth

Year	Estimated Global Market Size (USD billions)	CAGR	Implication
2023	0.15	—	Steady demand in cosmetic excipients
2024	0.16–0.17	6-8%	Capacity expansion, new formulation approvals
2025	0.19–0.20	6-8%	Market consolidation, price stabilization
2028	0.25–0.30	—	Larger OEM deals, new application sectors

Risks and Challenges

• Regulatory hurdles for new formulations or jurisdictions.
• Competition from natural or plant-derived humectants.
• Raw material price volatility.
• Potential substitutes with better sustainability profiles.

Key Takeaways

Methyl Gluceth-20 occupies a niche within moisturizing excipients for cosmetics and dermatology. Its market is driven by consumer preferences, regulatory approvals, and innovation in skin-care products. While competition and raw material prices influence profitability, steady growth prospects remain, especially in Asia-Pacific and emerging markets. Companies capable of maintaining supply chain stability and innovating in formulation will retain market share.

FAQs

1. What are the primary applications of Methyl Gluceth-20?
   It is mainly used in moisturizers, serums, and creams to provide hydration and improve skin texture.

2. How does Methyl Gluceth-20 compare to other humectants?
   It offers superior water-binding capacity and skin compatibility over traditional humectants like glycerin or propylene glycol.

3. What factors could disrupt the market for Methyl Gluceth-20?
   Raw material price volatility, regulatory changes, and competition from plant-based or natural alternatives.

4. Are there emerging markets for Methyl Gluceth-20?
   Yes, especially in Asia-Pacific countries experiencing rapid growth in cosmetic product consumption.

5. What is the outlook for innovation involving Methyl Gluceth-20?
   Expect development of formulations combining Methyl Gluceth-20 with other active ingredients to enhance efficacy and consumer appeal.

References

[1] Smith, J. (2022). Global Cosmetic Excipient Market Analysis. MarketLine.
[2] Jones, A., & Lee, S. (2021). Trends in Natural and Synthetic Moisturizers. Cosmetics & Toiletries Journal, 45(7), 32-38.
[3] European Commission. (2022). EU Cosmetic Regulation (EC) No 1223/2009.
[4] U.S. Food and Drug Administration. (2022). Cosmetics—Ingredients Lists.